An Open-label Study Evaluating the Safety, Antiviral Activity, and Pharmacokinetics of IMC-I109V in HLA-A*02:01 Positive Patients with Chronic HBV who are Non-Cirrhotic, Hepatitis B e Antigen-negative, and Virally Suppressed

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Mitchell, Joanne L. (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date12/01/24 → 11/01/26

Keywords

  • Clinical trial
  • IMC‑I109V-101